Potassium citrate supplementation with ketogenic dietary therapy for drug‐resistant epilepsy

Schoeler, Natasha E.

doi:10.1111/dmcn.14418

Cited by 1 publication

(2 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Specifically, 2-oxoglutarate also known as a-ketoglutarate is an important intermediate in TCA cycle and is known to affect glutamate and GABA levels in the brain 58 . Similarly, the dietary intake of 2-oxoglutarate (a-ketoglutarate) decreases the a-synuclein pathology in mouse model of Parkinson's disease 59 . Even though this metabolite has been implicated in neurophysiological conditions, how microbial levels of 2-oxoglutarate and other intermediate metabolites from the TCA cycle, may affect the brain to alter anti-seizure susceptibility is unknown.…”

Section: Glutamate Biosynthesis Was Positively Associated With the Pr...mentioning

confidence: 99%

“…Even though this metabolite has been implicated in neurophysiological conditions, how microbial levels of 2-oxoglutarate and other intermediate metabolites from the TCA cycle, may affect the brain to alter anti-seizure susceptibility is unknown. During KD therapy, patients supplemented with oral citrate as an alkalizing agent prevented metabolic acidosis without affecting the 7-month efficacy rates 59 . Similarly, KD has been shown to affect the succinate levels through succinate dehydrogenase activity in rodent models of aging 60 and through effects on mitochondrial respiration to restore ATP production 61 .…”

Section: Glutamate Biosynthesis Was Positively Associated With the Pr...mentioning

confidence: 99%

See 1 more Smart Citation

Dietary fiber content in clinical ketogenic diets modifies the gut microbiome and seizure resistance in mice

Özcan,

Yu,

Dinh

et al. 2024

Preprint

View full text Add to dashboard Cite

The gut microbiome is emerging as an important modulator of the anti-seizure effects of the classic ketogenic diet. However, many variations of the ketogenic diet are used clinically to treat refractory epilepsy, and how different dietary formulations differentially modify the gut microbiome in ways that impact seizure outcome is poorly understood. We find that clinically prescribed ketogenic infant formulas vary in macronutrient ratio, fat source, and fiber content and also in their ability to promote resistance to 6-Hz psychomotor seizures in mice. By screening specific dietary variables for their effects on a model human infant microbial community, we observe that dietary fiber, rather than fat ratio or source, drives substantial metagenomic shifts. Addition of dietary fiber to a fiber-deficient ketogenic formula restores seizure resistance, and supplementing protective ketogenic formulas with excess dietary fiber further potentiates seizure resistance. By screening 13 fiber sources and types, we identify distinct subsets of metagenomic responses in the model human infant microbial community that correspond with increased seizure resistance in mice. In particular, supplementation with seizure-protective fibers enriches microbial representation of genes related to queuosine biosynthesis and preQ0biosynthesis and decreases representation of microbial genes related to sucrose degradation, which is also seen in seizure-protected mice that are fed fiber-containing ketogenic infant formulas. Overall, this study reveals that different formulations of clinical ketogenic diets, and dietary fiber content in particular, differentially impact seizure outcome in mice, likely through modification of the gut microbiome. Understanding interactions between dietary components of the ketogenic diet, the gut microbiome, and host susceptibility to seizures could inform novel microbiome-guided approaches to treat refractory epilepsy.

show abstract

Section: Glutamate Biosynthesis Was Positively Associated With the Pr...mentioning

confidence: 99%

Section: Glutamate Biosynthesis Was Positively Associated With the Pr...mentioning

confidence: 99%

Dietary fiber content in clinical ketogenic diets modifies the gut microbiome and seizure resistance in mice

Özcan,

Yu,

Dinh

et al. 2024

Preprint

View full text Add to dashboard Cite

show abstract

Potassium citrate supplementation with ketogenic dietary therapy for drug‐resistant epilepsy

Abstract: This commentary is on the original article by Bjurulf et al. on pages 57‐61 of this issue.

Cited by 1 publication

References 6 publications

Dietary fiber content in clinical ketogenic diets modifies the gut microbiome and seizure resistance in mice

Dietary fiber content in clinical ketogenic diets modifies the gut microbiome and seizure resistance in mice

Contact Info

Product

Resources

About